UBS Group’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-65,000
Closed -$537K 10615
2024
Q4
$537K Buy
+65,000
New +$521K ﹤0.01% 5786
2019
Q4
Sell
-427,700
Closed -$3.66M 8339
2019
Q3
$3.66M Sell
427,700
-238,000
-36% -$2.33M ﹤0.01% 2680
2019
Q2
$7.66M Buy
+665,700
New +$8.57M ﹤0.01% 1975
2015
Q4
Sell
-25,100
Closed -$330K 8523
2015
Q3
$330K Buy
25,100
+12,600
+101% +$200K ﹤0.01% 4229
2015
Q2
$235K Buy
+12,500
New +$259K ﹤0.01% 4730
2015
Q1
Sell
-157,400
Closed -$2.61M 9245
2014
Q4
$2.61M Buy
+157,400
New +$3.32M ﹤0.01% 2646

Other funds holding PTEN

UBS Group's PTEN Position: Q1 2026 in Review

UBS Group reduced its Patterson-UTI (PTEN) stake by 65% in Q1 2026, selling an estimated $46.2M and leaving 2,919,491 shares worth $31.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2112.

UBS Group first reported a position in PTEN in Q4 2014 and has held it in 46 quarters since. The position peaked at $50.8M in Q4 2025. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • UBS Group held 2,919,491 shares of Patterson-UTI worth $31.6M as of Q1 2026.
  • UBS Group sold 5,401,053 Patterson-UTI shares in Q1 2026, an estimated $46.2M.
  • Patterson-UTI made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2112 holding.
  • UBS Group first reported a position in Patterson-UTI in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Patterson-UTI position peaked at $50.8M in Q4 2025.
  • 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.